首页> 外国专利> APPLICATION OF DNA-DIAGNOSTICS FOR PRESENCE OF POLYMORPHISM R353Q IN GENE OF FACTOR VII OF BLOOD COAGULATION FOR ESTIMATION OF PREDISPOSITION TO DEVELOPMENT OF HABITUAL NONCARRYING OF PREGNANCY AND METHOD OF PREDISPOSITION ESTIMATION TO THIS DISEASE BY MEANS OF ANALYSIS OF COMBINATION OF POLYMORPHISMS C677T OF GENE MTHFR AND OF GENE R353Q OF FACTOR VII

APPLICATION OF DNA-DIAGNOSTICS FOR PRESENCE OF POLYMORPHISM R353Q IN GENE OF FACTOR VII OF BLOOD COAGULATION FOR ESTIMATION OF PREDISPOSITION TO DEVELOPMENT OF HABITUAL NONCARRYING OF PREGNANCY AND METHOD OF PREDISPOSITION ESTIMATION TO THIS DISEASE BY MEANS OF ANALYSIS OF COMBINATION OF POLYMORPHISMS C677T OF GENE MTHFR AND OF GENE R353Q OF FACTOR VII

机译:DNA诊断法在血液凝集因子VII基因中存在多态性R353Q的应用中,通过多态性和多聚体C677结合的分析手段,可以预测人的习惯性妊娠发生的倾向性,以及该病的倾向性估计方法因子VII R353Q的分析

摘要

FIELD: technological processes.;SUBSTANCE: invention is related to the field of molecular biology and genetics and may be used in medicine for determination of risk of development of habitual noncarrying of pregnancy (HN). Correlation was established between polymorphism R353Q of gene of blood coagulation factor VII and development of HN, and possibility of using results of DNA analysis for the presence of the mentioned polymorphism is shown in estimation of genetic predisposition to this disease. Method is suggested to predict predisposition for development of HN, which includes simultaneous testing of DNA for presence of polymorphism R353Q of blood coagulation gene factor VII and polymorphism C677T of gene methylene- tetrahydropholatereductase (MTHFR), determination of patient genotype with account of data on two investigated genes and drawing conclusion, where genotype RRTT is qualified as highly unfavorable, genotypes RRCC, RRCC and RQTT - as unfavorable, genotypes RQCC and RQCT - as favourable prognostic criteria.;EFFECT: increase of prognostication efficiency.;2 cl, 7 dwg, 1 tbl, 5 ex
机译:发明领域本发明涉及分子生物学和遗传学领域,并且可以用于医学中确定习惯性不携带妊娠(HN)的发展风险。在凝血因子VII基因的多态性R353Q和HN的发展之间建立了相关性,并且在对该疾病的遗传易感性的估计中显示了使用DNA分析结果来检测所述多态性的可能性。建议使用方法来预测HN的易感性,其中包括同时检测DNA中凝血基因VII的多态性R353Q和亚甲基四氢磷酸还原酶(MTHFR)的多态性C677T的存在,根据两个患者的数据确定患者的基因型研究基因并得出结论,其中RRTT基因型被定为高度不利,而RRCC,RRCC和RQTT基因型被定为不利,基因型RQCC和RQCT被定为良好的预后标准;效果:提高预后效率; 2 cl,7 dwg, 1汤匙,5前

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号